Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza, a CDMO partner to the biopharma industry, announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement. At scale, and following ...
read more
Thermo Fisher Scientific Inc., has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
read more
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
read more
Catalent announced the launch of a next-generation cell line development technology, GPEx® Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx ...
read more
Vetter, a leading global Contract Development and Manufacturing?Organization?(CDMO) has further?invested in additional?capacity to meet this growing global demand in Rankweil, Austria. The site has been modified to the high Vetter quality standards ...
read more
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ...
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more
With its acquisition of IRISYS, Recro has transformed itself into a full-service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-...
read more
ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. FDA approval for its ADMA BioCenters plasma ...
read more
Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial cell therapies...
read more
Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction. Slated for completion in Q4 2022, the new site...
read more
TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt. Governor David Toland, Shawnee Mayor Michelle Distler, State Senator Mike Thompson, Congresswoman Jo Ella Hoye, Congresswoman Cindy Neighbor, other Shawnee city ...
read more
Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced that its Board of Directors has appointed Timothy Compton as Chief Business Officer. Mr. Compton, who brings over 25-years of industry experience ...
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility. The increased capability to flexibly manufacture ...
read more
Beroni Group, an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical ...
read more